Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis

Conclusions: Post-infliximab induction FC can be used as a surrogate marker for predicting clinical remission and mucosal healing in refractory UC patients.

Source: The Saudi Journal of Gastroenterology - July 17, 2017 Category: Gastroenterology Authors: Elham A Hassan Haidi K Ramadan Ali A Ismael Khaled F Mohamed Madiha M El-Attar Ihab Alhelali Source Type: research